Matthew Scholz
Chief Executive Officer
Oisin BioTechnologiesSeattle, Washington, United States
3 investmentsMatthew Scholz is a Chief Executive Officer at Oisin BioTechnologies based in Seattle, Washington, United States. Matthew Scholz has backed 3 companies, including Immusoft, Oisin BioTechnologies and Point B Telematics. Investment focus areas include Android, Software and Biotechnology.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Access Full Contact Information
Get Matthew Scholz's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
3-day free trial, cancel anytime
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.